Radioimmunoassay of ACTH in plasma.
Techniques are described in detail for a radioimmunoassay of plasma adrenocorticotropin (ACTH) that is capable of detecting hormone in unextracted normal human plasma at 1:5 dilution under the conditions described. The sensitivity of the assay is at the level of 1 mumug/ml (equivalent to 0.014 mU/100 ml). In normal subjects ACTH concentrations averaged 22 mumug/ml (equivalent to 0.308 mU/100 ml) plasma at 8-10 a.m. In a smaller group the concentrations averaged 9.6 mumug/ml (equivalent to 0.134 mU/100 ml) at 10-11 p.m. Although a circadian rhythm in normal subjects was not always well marked throughout the daytime hours, plasma ACTH usually fell to its lowest value in the late evening. In hospital patients who were not acutely ill, concentrations were infrequently above 100 mumug/ml in the morning and usually fell to significantly lower levels in the late evening. Severely ill hospital patients occasionally exhibited a.m. concentrations above 200 mumug/ml. In a group of subjects showing frequent spiking of plasma 17-OHCS concentrations throughout the day parallel spiking of plasma ACTH as well was generally observed.Metyrapone produced marked increases in plasma ACTH within 24 hr in all cases and generally within 3-6 hr except when started late in the day. Dexamethasone brought about a persistent reduction in plasma ACTH in a patient under continued treatment with metyrapone.Hypoglycemia, electroshock, surgery under general anesthesia, histalog and vasopressin administration were usually followed by significant increases in plasma ACTH concentration. Prior administration of dexamethasone blocked the response to hypoglycemia. Marked elevations in plasma ACTH were observed in patients with adrenal insufficiency off steroid therapy, in Cushing's disease after adrenalectomy even in the presence of persistent hypercortisolemia, and in some untreated patients with Cushing's disease. Umbilical cord blood contained higher plasma ACTH concentrations than maternal blood at delivery in seven of eight cases. After suppression of ACTH secretion by dexamethasone or cortisol. ACTH disappeared from plasma with half-times ranging from 22 min to 30 min in three cases studied.
D015065:17-Hydroxycorticosteroids / Q000097:blood; D000307:Adrenal Gland Diseases / Q000097:blood; D000310:Adrenal Gland Neoplasms / Q000097:blood; D000312:Adrenal Hyperplasia, Congenital / Q000097:blood; D000324:Adrenocorticotropic Hormone / Q000097:blood* / Q000378:metabolism; D000818:Animals; D000906:Antibodies; D001786:Blood Glucose / Q000032:analysis; D002845:Chromatography; D002940:Circadian Rhythm; D003480:Cushing Syndrome / Q000097:blood; D036861:Delivery, Obstetric; D003907:Dexamethasone / Q000494:pharmacology; D004565:Electroconvulsive Therapy; D004586:Electrophoresis; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D007003:Hypoglycemia / Q000097:blood; D007018:Hypopituitarism / Q000097:blood; D007456:Iodine Isotopes; D008722:Methods; D008797:Metyrapone / Q000494:pharmacology; D010673:Pheochromocytoma / Q000097:blood; D011247:Pregnancy; D011720:Pyrazoles / Q000494:pharmacology; D011863:Radioimmunoassay; D013514:Surgical Procedures, Operative
D015065:17-Hydroxycorticosteroids; D000906:Antibodies; D001786:Blood Glucose; D007456:Iodine Isotopes; D011720:Pyrazoles; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone; D008797:Metyrapone